Burrill Conferences


PlatinumPresented withSilver

Life Sciences Conferences

The Pacific Northwest Life Sciences Meeting


May 6, 2008
8:00–8:30 a.m.
Breakfast & Registration

8:30–9:30 am
Welcome & Keynote Presentation: Biotech State of the World
G. Steven Burrill, CEO, Burrill & Company

9:30–10:30 am
Panel: Life Science Progress/Problems in the Pacific Northwest

Karimah Es Sabar, President, Life Sciences British Columbia
Jack Faris, President, Washington Biotechnology & Biomedical Association
Matt Gardner, President and CEO, Baybio
Bob Lanier, President, Oregon Bioscience Association
Moderated by:
David Almodovar, Vice President, Credit Suisse
Zack Scott, Director, Burrill & Company

10:30–10:45 am

10:45 a.m.–12:00 pm
Company Presentations
Dimera, R. Kent Hermsmeyer, President
Electrical Geodesics, Don Tucker, CEO
Floragenex, Nathan Lillegard, President
Molecular MD, Sheridan Snyder, CEO
Vesticon, Cathryn Epley, CEO and President

12:00–1:00 pm
Networking Lunch

1:00–2:00 pm
Keynote Presentation: TBA

2:00–3:15 pm
Panel: Success Stories in the Pacific Northwest

Adolph Ferro, President and CEO, Artielle Imunotherapeutics
Robert Hershberg, EVP and CMO, VentiRx
Sri Nagalla, CSO, ProteoGenix
Richard A. Sessions, CEO, Znomics
Mike Wright, President and CEO, Wellpartner
Moderated by:
John Hamer, Managing Director, Burrill & Company

3:15–3:30 pm

3:30–4:30 pm
Panel: Capital Markets and Capital Market Availability for Pacific Northwest Companies in Today’s Markets

Bill Newman, Managing Director, Northwest Technology Ventures
Carl Weissman, President & CEO, Accelerator Corporation
Moderated by:
Giovanni Ferrara, Managing Director, Burrill & Company

4:30–5:00 pm
2020 Vision for Biotech and how it applies to The Pacific Northwest–What’s next

G. Steven Burrill, CEO, Burrill & Company

5:00–7:00 pm
Networking Reception